Trials / Conditions / CIS
CIS
4 registered clinical trials studyying CIS.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta NCT06390111 | Ferring Pharmaceuticals | Phase 4 |
| Terminated | A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjec NCT01314664 | Endo Pharmaceuticals | — |
| Completed | Study To Determine The Maximum Range of Light Doses At Two HPPH Doses With Acceptable Normal Tissue Toxicity F NCT01238042 | Roswell Park Cancer Institute | Phase 1 |
| Completed | Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus NCT01236443 | Roswell Park Cancer Institute | Phase 1 |